School of Pharmacy, Bengbu Medical College, Bengbu Anhui 233030.
Anhui Province Biochemical Pharmaceutical Engineering Technology Research Center, Bengbu Anhui 233030, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Aug 28;48(8):1128-1135. doi: 10.11817/j.issn.1672-7347.2023.230061.
Nasopharyngeal cracinoma is a kind of head and neck malignant tumor with high incidence and high mortality. Due to the characteristics of local recurrence, distant metastasis, and drug resistance, the survival rate of patients after treatment is not high. Paclitaxel (PTX) is used as a chemotherapy drug in treating nasopharyngeal carcinoma, but nasopharyngeal carcinoma cells are easy to develop resistance to PTX. Inhibition of heat shock protein 90 (Hsp90) can overcome common signal redundancy and resistance in many cancers. This study aims to investigate the anti-tumor effect of ginkgolic acids C15꞉1 (C15:1) combined with PTX on nasopharyngeal carcinoma CNE-2Z cells and the mechanisms.
This experiment was divided into a control group (without drug), a C15:1 group (10, 30, 50, 70 μmol/L), a PTX group (5, 10, 20, 40 nmol/L), and a combination group. CNE-2Z cells were treated with the corresponding drugs in each group. The proliferation of CNE-2Z cells was evaluated by methyl thiazolyl tetrazolium (MTT). Wound-healing assay and transwell chamber assay were used to determine the migration of CNE-2Z cells. Transwell chamber was applied to the impact of CNE-2Z cell invasion. Annexin V-FITC/PI staining was used to observe the effect on apoptosis of CNE-2Z cells. The changes of proteins involved in cell invasion, migration, and apoptosis after the combination of C15꞉1 and PTX treatment were analyzed by Western blotting.
Compared with the control group, the C15꞉1 group and the PTX group could inhibit the proliferation of CNE-2Z cells (all <0.05). The cell survival rates of the C15꞉1 50 μmol/L combined with 5, 10, 20, or 40 nmol/L PTX group were lower than those of the single PTX group (all <0.05), the combination index (CI) value was less than 1, suggesting that the combined treatment group had a synergistic effect. Compared with the 50 μmol/L C15꞉1 group and the 10 nmol/L PTX group, the combination group significantly inhibited the invasion and migration of CNE-2Z cells (all <0.05). The results of Western blotting demonstrated that the combination group could significantly down-regulate Hsp90 client protein matrix metalloproteinase (MMP)-2 and MMP-9. The results of double staining showed that compared with the 50 μmol/L C15꞉1 group and the 10 nmol/L PTX group, the apoptosis ratio of CNE-2Z cells in the combination group was higher (both <0.05). The results of Western blotting suggested that the combination group could decrease the Hsp90 client proteins [Akt and B-cell lymphoma-2 (Bcl-2)] and increase the Bcl-2-associated X protein (Bax).
The combination of C15꞉1 and PTX has a synergistic effect which can inhibit cell proliferation, invasion, and migration, and induce cell apoptosis. This effect may be related to the inhibition of Hsp90 activity by C15꞉1.
鼻咽癌是一种发病率和死亡率都很高的头颈部恶性肿瘤。由于局部复发、远处转移和耐药性的特点,治疗后患者的生存率不高。紫杉醇(PTX)被用作治疗鼻咽癌的化疗药物,但鼻咽癌细胞容易对 PTX 产生耐药性。抑制热休克蛋白 90(Hsp90)可以克服许多癌症中常见的信号冗余和耐药性。本研究旨在探讨 15-羟基-11-二十二碳烯酸(C15:1)与 PTX 联合应用对鼻咽癌细胞 CNE-2Z 的抗肿瘤作用及其机制。
实验分为对照组(无药物)、C15:1 组(10、30、50、70 μmol/L)、PTX 组(5、10、20、40 nmol/L)和联合组。各组 CNE-2Z 细胞分别用相应药物处理。采用甲基噻唑基四唑(MTT)法评价 CNE-2Z 细胞的增殖。划痕愈合试验和 Transwell 室试验用于测定 CNE-2Z 细胞的迁移。Transwell 室用于测定 CNE-2Z 细胞的侵袭。用 Annexin V-FITC/PI 染色观察 CNE-2Z 细胞凋亡的影响。用 Western blot 分析 C15꞉1 与 PTX 联合处理后细胞侵袭、迁移和凋亡相关蛋白的变化。
与对照组相比,C15:1 组和 PTX 组均可抑制 CNE-2Z 细胞的增殖(均<0.05)。C15꞉1 50 μmol/L 联合 5、10、20、40 nmol/L PTX 组的细胞存活率均低于单独 PTX 组(均<0.05),联合指数(CI)值<1,提示联合治疗组具有协同作用。与 50 μmol/L C15꞉1 组和 10 nmol/L PTX 组相比,联合组显著抑制 CNE-2Z 细胞的侵袭和迁移(均<0.05)。Western blot 结果表明,联合组可显著下调 Hsp90 客户蛋白基质金属蛋白酶(MMP)-2 和 MMP-9。双染结果显示,与 50 μmol/L C15꞉1 组和 10 nmol/L PTX 组相比,联合组 CNE-2Z 细胞的凋亡率更高(均<0.05)。Western blot 结果表明,联合组可降低 Hsp90 客户蛋白[Akt 和 B 细胞淋巴瘤-2(Bcl-2)],增加 Bcl-2 相关 X 蛋白(Bax)。
C15꞉1 与 PTX 联合具有协同作用,可抑制细胞增殖、侵袭和迁移,并诱导细胞凋亡。这种作用可能与 C15꞉1 抑制 Hsp90 活性有关。